Patent · US Active

Partial region polypeptide of REIC/Dkk-3 protein

US9644013B2 · kind B2 · utility

2Cited by
0References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 15, 2016
Grant dateMay 9, 2017
Priority date
Expiry dateJan 15, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A polypeptide capable of strongly inducing and activating dendritic-cell-like cells for treating or prevent cancer by immunotherapy, and DNA encoding the polypeptide. The polypeptide is a polypeptide (a) or (b) consisting of a partial region of the REIC/Dkk-3 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.